Additional file 1 of Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
Additional file 1: Supplementary information. Table S1. Further information on patients withdrawn from the trial due to worsening COVID19/ escalation to WHO Scale >4. Table S2. Summary of adverse events recorded for both groups. Figure S1. Kaplan Meier plot to show risk of patient escalating to WHO OS >4. Figure S2. Additional clinical biomarkers.